GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease Progression
17. Oktober 2023 08:35 ET
|
GRI Bio, Inc.
UK consortia brings together internationally recognized investigators in the UK's leading centers of excellence to carry out experimental and early phase research Translational work to be...
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
23. August 2023 09:00 ET
|
GRI Bio, Inc.
Aardvark to acquire global development and commercialization rights to ADAIR and all intellectual property outside of Europe and licensor rights for the EU Aardvark to leverage ADAIR formulation...
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Event
24. Juli 2023 09:00 ET
|
GRI Bio, Inc.
- Live moderated webcast with members of the GRI Bio management team on Thursday, July 27th at 1:00 PM ET LA JOLLA, CA, July 24, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio”...
NKT tildelt rekordordrer til verdens første 525 kV XLPE HVDC kabelprojekter til havvind
03. März 2023 02:15 ET
|
Nkt A/S
Selskabsmeddelelse 3. marts 2023 Meddelelse nr. 7NKT tildelt rekordordrer til verdens første 525 kV XLPE HVDC kabelprojekter til havvind NKT er blevet tildelt tre turnkey kabelprojekter til...
NKT awarded record orders for world’s first 525 kV XLPE HVDC submarine cable projects for offshore wind
03. März 2023 02:15 ET
|
Nkt A/S
Company Announcement 3 March 2023 Announcement No. 7 NKT awarded record orders for world’s first 525 kV XLPE HVDC submarine cable projects for offshore wind NKT has been awarded...
Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
24. Februar 2023 07:30 ET
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), today reported its financial results for the fiscal year ended December...
Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event
11. Januar 2023 08:45 ET
|
Vallon Pharmaceuticals Inc.
Live video webcast on Tuesday, January 17, 2023 at 1:00 PM ET PHILADELPHIA, PA and LA JOLLA, CA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the...
NKT bekræfter ordre på Dogger Bank havvindmølleparkerne Creyke Beck A/B
19. November 2019 07:21 ET
|
Nkt A/S
Selskabsmeddelelse 19. november 2019 Meddelelse nr. 14 NKT bekræfter ordre på Dogger Bank havvindmølleparkerne Creyke Beck A/BSom informeret i Selskabsmeddelelse nr. 11 af 20. september 2019, har...
NKT confirms order for Dogger Bank offshore Wind Farms Creyke Beck A/B
19. November 2019 07:21 ET
|
Nkt A/S
Company Announcement 19 November 2019 Announcement No. 14 NKT confirms order for Dogger Bank offshore Wind Farms Creyke Beck A/BAs informed in Company Announcement no. 11 of 20 September 2019, NKT...
NKT bekræfter turnkey ordre på havvindmølleprojektet Moray East
02. November 2018 14:23 ET
|
Nkt A/S
Selskabsmeddelelse 2. november 2018 Meddelelse nr. 15 NKT bekræfter turnkey ordre på havvindmølleprojektet Moray East Som informeret i selskabsmeddelelse nr. 30 af 13. november 2017, havde NKT...